Tissue Engineering Global Market Size ($26.33 Billion Revenue By 2028) Growing Rapidly with Recent Trends and Outlook

"The new report published by The Business Research Company, titled ""Tissue Engineering Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the tissue engineering market size has grown rapidly in recent years. It will grow from $13.36 billion in 2023 to $15.38 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $26.33 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9535&type=smp

Rising Prevalence Of Chronic Diseases And Trauma Emergencies Fueling Tissue Engineering Market Growth
The increase in the prevalence of chronic diseases and trauma emergencies is expected to propel the growth of the tissue engineering market going forward. Chronic diseases refer to clinical conditions that last for 3 months or longer periods and usually can be controlled but not cured, whereas trauma emergencies refer to any physical injury that requires immediate medical attention due to its sudden onset and severity such as traumatic brain injuries. Tissue engineering is widely adopted by healthcare professionals for its various advantage in treating chronic disorders and trauma to avoid end-stage treatment failure including autologous or allograft transplantation, xenotransplantation, and artificial substitutes. For instance, in March 2021, according to the Mary Ann Liebert, Inc. article, a US-based privately held independent publishing company, approximately 2% of the total population in the United States are affected by chronic wounds. Further, in 2020, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency that operates in the prevention and control of disease and injury, around 64,000 occurred in the United States due to traumatic brain injuries and approximately176 deaths every day by TBI. Therefore, the increase in the prevalence of chronic diseases and trauma emergencies is driving the growth of the tissue engineering market.

Technological Advancements Propelling Tissue Engineering Market Growth
Technological advancement is the key trend that is gaining popularity in the tissue engineering market. Major companies operating in the market are focused on research and development for product innovations that could give better solutions and strengthen their position in the market. For instance, in March 2021, CELLINK, a US-based company operating in tissue engineering introduced its advanced bioprinter that works on 3D bioprinting technology known as BIO MDX Series. 3D bioprinting technology refers to technology that uses bio-inks and living cells to construct natural 3D tissue structures. BIO MDX Series consists of printheads, nanoliter, and picoliter dispensing channels along with robotic integration that provides precision bioprinting for high-throughput fabrication that can be used in advanced cell-based technologies.

The tissue engineering market covered in this report is segmented -
1) By Type: Synthetic Scaffold Material, Biologically Derived Scaffold Material, Other Types
2) By Application: Orthopedics And Musculoskeletal, Neurology, Cardiovascular, Skin And Integumentary, Dental, Other Applications,,,,
3) By End-User: Hospitals And Clinics, Ambulatory Facilities

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9535&type=discount

Major companies operating in the tissue engineering market report are Medtronic plc, Zimmer Biomet, Allergan plc, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, Acelity L.P. Inc., B. Braun Melsungen AG, RTI Surgical Inc., AbbVie Inc., Becton Dickinson and Company, Baxter International Inc., Osiris Therapeutics Inc., Organovo Inc., BioTime Inc., Bio Tissue Technologies, Vericel Corporation, Smith and Nephew, Acell Inc., Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Butterfly Network Inc., iThera Medical GmbH, Bit Bio, Be Biopharma Inc., The Takeda Pharmaceutical Company, Frequency Therapeutics, TELA Bio Inc., Orthocell Limited .

Contents of the report:
1. Executive Summary
2. Tissue Engineering Market Report Structure
3. Tissue Engineering Market Trends And Strategies
4. Tissue Engineering Market - Macro Economic Scenario
5. Tissue Engineering Market Size And Growth
…..
27. Tissue Engineering Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.